Mens Sana Monogr. 2007 Jan-Dec; 5(1): 134–135. doi: 10.4103/0973-1229.32158 PMCID: PMC3192377 What is the ideal combination of increased investment in biomedical research by sponsors with

Mens Sana Monogr. 2007 Jan-Dec; 5(1): 128–133. doi: 10.4103/0973-1229.32157 PMCID: PMC3192376 Private investment in biomedical research has increased over the last few decades. At most

Mens Sana Monogr. 2007 Jan-Dec; 5(1): 121–127. doi: 10.4103/0973-1229.32156 PMCID: PMC3192375 In this final section, we shall see what are the ground realities that both

Mens Sana Monogr. 2007 Jan-Dec; 5(1): 116–121. doi: 10.4103/0973-1229.32155 PMCID: PMC3192374 In this section, we look at how the biological paradigm shift in psychiatry has

Mens Sana Monogr. 2007 Jan-Dec; 5(1): 113–116. doi: 10.4103/0973-1229.32154 PMCID: PMC3192373 In this section we look into the difference between useful and marketable entities, how

Mens Sana Monogr. 2007 Jan-Dec; 5(1): 107–112. doi: 10.4103/0973-1229.32153 PMCID: PMC3192371 Chapter V on Foundations and Task Forces discussed issues related to research obligations towards

Mens Sana Monogr. 2007 Jan-Dec; 5(1): 90–107. doi: 10.4103/0973-1229.32152 PMCID: PMC3192397 This section will detail some important initiatives taken by journal editors in writing about

Mens Sana Monogr. 2007 Jan-Dec; 5(1): 79–89. doi: 10.4103/0973-1229.32151 PMCID: PMC3192396 This chapter looks into how Foundations are influenced by Industry in the light of

Mens Sana Monogr. 2007 Jan-Dec; 5(1): 56–78. doi: 10.4103/0973-1229.32150 PMCID: PMC3192395 This section reports the findings and recommendations of an important Conference on Guidelines Standardisation